Skip to main content

Latest News

XBiotech Cancer Drug Survival Claim Falls Apart Under Scrutiny
STOCKS
XBITGTXI

XBiotech cancer drug survival claim falls apart under scrutiny

By Adam Feuerstein
Jul 5, 2016 8:35 AM EDT
Jim Cramer -- Stocks Went From Hungover to Drunk in 24 Hours
INVESTING
GTXIRGSEVGGL

3 Stocks Under $10 to Trade for Big Breakouts

By Roberto Pedone
Apr 30, 2015 2:33 PM EDT
Hedge Funds Love These 5 Consumer Stocks -- but Should You?
INVESTING
GTXIMEIPRXDX

4 Biotech Stocks Under $10 to Watch for Breakout Trades

By Roberto Pedone
Jul 2, 2014 8:18 AM EDT
5 Stocks Insiders Love Right Now
INVESTING
AROGOLGTXI

5 Stocks Ready for Breakouts

By Roberto Pedone
Sep 16, 2013 9:53 AM EDT
3 Stocks Breaking Out on Unusual Volume
INVESTING
DRRXECTEGTXI

6 Under-$10 Stocks Moving Higher

By Roberto Pedone
Sep 11, 2013 8:57 AM EDT

Recommended for You

PRESS RELEASES

Guardant Health Presents New Data Showing Blood Test Accuracy In Detecting Colorectal Cancer In First-of-its Kind Prospective Study At Digestive Disease Week 2022

By Business Wire
PRESS RELEASES

INVESTOR NOTICE: Upstart Holdings, Inc. Investors With Substantial Losses Have Opportunity To Lead The Class Action Lawsuit - UPST

By Business Wire
PRESS RELEASES

INVESTOR DEADLINE: Axsome Therapeutics, Inc. Investors With Substantial Losses Have Opportunity To Lead Class Action Lawsuit - AXSM

By Business Wire
PRESS RELEASES

INVESTOR ALERT: Okta, Inc. Investors With Substantial Losses Have Opportunity To Lead The Okta Class Action Lawsuit - OKTA

By Business Wire